Keyphrases
Ventricular Tachycardia
96%
Defibrillator Lead
80%
Implantable Defibrillator
75%
Pivotal Trial
52%
Primary Prevention
51%
Major Complications
49%
Safety Efficacy
48%
Efficacy Evaluation
48%
Safety Reliability
48%
Small Diameter
48%
Trial Results
48%
Safety Assessment
48%
Reliability Evaluation
48%
Defibrillation
44%
Implantable Cardioverter-defibrillator Therapy
44%
Atrial Fibrillation
39%
Ablation
38%
Electrophysiology
35%
Intracardiac
34%
Electrocardiographic Imaging
33%
Catheter
33%
Lead Fracture
32%
Safety Objective
32%
Shared Decision Making
32%
Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
32%
Clinical Experience
32%
Echocardiographic Guidance
32%
Intracardiac Echocardiography
32%
Arrhythmia
30%
Implantable Cardioverter-defibrillator Shock
28%
All-cause Mortality
26%
Ischemic Cardiomyopathy
26%
Sudden Cardiac Death
26%
Radiofrequency Ablation
24%
Ventricular Arrhythmia
23%
Electrophysiological Study
23%
Hazard Ratio
22%
Supraventricular Tachycardia
22%
Scar
21%
Electroanatomic Mapping
21%
Cardiomyopathy
20%
Programmed Ventricular Stimulation
20%
Fluoroscopy
20%
Cardiac Ablation
19%
Cardiac Resynchronization Therapy
19%
Kaplan-Meier
19%
CRT-D
19%
Anticoagulation
18%
Dual-chamber Pacemaker
18%
Risk Assessment
18%
Medicine and Dentistry
Ventricular Tachycardia
100%
Implantable Automatic Defibrillator
95%
Defibrillator
74%
Defibrillation
64%
Primary Prevention
48%
Electrophysiology
44%
Atrial Fibrillation
33%
Intracardiac Echocardiography
32%
Shock (Circulatory)
29%
Sudden Cardiac Death
29%
Cardiac Dysrhythmia
28%
Heart Ventricle Arrhythmia
28%
Cardiac Resynchronization Therapy
26%
Fluoroscopy
24%
Radiofrequency Ablation
24%
Monomorphic Ventricular Tachycardia
24%
All Cause Mortality
22%
Ischemic Cardiomyopathy
21%
Supraventricular Tachycardia
21%
Myocardial Disease
20%
Antitachycardia Pacing
18%
Electrocardiogram
18%
Congestive Heart Failure
17%
Long Term Survival
17%
Faintness
16%
Artery Injury
16%
Coronary Artery Disease
16%
AV Nodal Reentrant Tachycardia
16%
Tachyarrhythmia
16%
Catheterization
16%
Azygos
16%
Sudden Death
16%
Chronic Kidney Disease
16%
Shared Decision Making
16%
Myocardium
16%
Adenosine Triphosphate
16%
Smoking
16%
Gap Junction
16%
Heart Atrium Pacing
16%
Central Sleep Apnea
16%
Phrenic Nerve
16%
Speech Production
16%
Lead Extraction
16%
Coronary Sinus
16%
Atrioventricular Nodal Reentry Tachycardia
16%
Lead Fracture
15%
Hazard Ratio
15%
Apoplexy
14%
Ventricular Fibrillation
14%
Neurostimulation
12%